Trademark: 86897301
Status Date
Wednesday, February 21, 2018
Filing Date
Thursday, February 4, 2016
Abandoned Date
Monday, January 29, 2018
5 (Based on Intent to Use) Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders and immunologically mediated inflammatory disorders(Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders and immunologically mediated inflammatory disorders
The wording "LIMTILYS" has no meaning in a foreign language.
Mar 6, 2018
Undeliverable Mail - Corresp. Remailed
Feb 21, 2018
Abandonment Notice Mailed - Failure To Respond
Feb 21, 2018
Abandonment - Failure To Respond Or Late Response
Jul 26, 2017
Notification Of Inquiry As To Suspension E-Mailed
Jul 26, 2017
Inquiry To Suspension E-Mailed
Jul 26, 2017
Suspension Inquiry Written
Jul 20, 2017
Lie Checked Susp - To Atty For Action
Jan 18, 2017
Notification Of Letter Of Suspension E-Mailed
Jan 18, 2017
Letter Of Suspension E-Mailed
Jan 18, 2017
Suspension Letter Written
Jan 18, 2017
Teas/Email Correspondence Entered
Jan 18, 2017
Correspondence Received In Law Office
Jan 9, 2017
Teas Response To Suspension Inquiry Received
Dec 2, 2016
Notification Of Inquiry As To Suspension E-Mailed
Dec 2, 2016
Inquiry To Suspension E-Mailed
Dec 2, 2016
Suspension Inquiry Written
Nov 29, 2016
Lie Checked Susp - To Atty For Action
Nov 18, 2016
Assigned To Lie
May 16, 2016
Notification Of Letter Of Suspension E-Mailed
May 16, 2016
Letter Of Suspension E-Mailed
May 16, 2016
Suspension Letter Written
May 12, 2016
Assigned To Examiner
Feb 9, 2016
New Application Office Supplied Data Entered In Tram
Feb 8, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
